이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Targeting Burdensomeness Among Clinic Referred Youth

2021년 5월 12일 업데이트: Florida International University
This study will develop and pilot test a novel intervention module targeting perceived burdensomeness toward others in 30 clinic referred youths who experience anxiety or depression and elevated levels of burdensomeness. All participants will be assigned to receive the intervention in this open trial.

연구 개요

상태

완전한

개입 / 치료

상세 설명

Suicidal ideation is prevalent and impairing in youth, with approximately 15% of high school students reporting seriously considering a suicide attempt and making a specific plan for suicide in the past 12 months. Substantial evidence documents perceived burdensomeness towards others, or the belief that one is a burden or drain on others, as a risk factor for suicide ideation in youth. This evidence highlights the potential promise of perceived burdensomeness as a novel intervention target to prevent suicide ideation in youth. The current study will develop and preliminary evaluate a novel, brief behavioral treatment module targeting perceived burdensomeness in youth that can be embedded within existing psychosocial treatments. The study will use an open trial design. The first aim of this proposal is to develop a novel, brief psychosocial intervention module (the GIVE module) targeting perceived burdensomeness towards others that can be embedded within existing CBT protocols for youth internalizing problems. The second aim is to collect data relevant to client satisfaction and reductions in perceived burdensomeness. Participants will be N=30 clinic-referred youth ages 10 to 17 years with anxiety or depressive disorders in a university-based research clinic, who display elevated levels of perceived burdensomeness. In the context on ongoing CBT for anxiety or depression, participants will complete the GIVE module at sessions 6 and 7 of the CBT protocol. It is hypothesized that perceived burdensomeness will be significantly lower after the GIVE module is administered, and that client satisfaction will be high. Data collected in this study will provide the foundation for a subsequent randomized controlled trial of the GIVE module.

연구 유형

중재적

등록 (실제)

18

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Florida
      • Miami, Florida, 미국, 33199
        • Florida International University Center for Children and Families

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

10년 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Clinical diagnosis of an anxiety disorder, persistent depressive disorder, or major depressive disorder
  • Score > 4 on the youth self-report Interpersonal Needs Questionnaire- Perceived Burdensomeness Scale

Exclusion Criteria:

  • Clinical diagnosis of a Psychotic Disorder, Autism Spectrum Disorder or Intellectual Disability
  • Show high risk of imminent self-injurious behaviors
  • Be involved currently in another behavioral treatment
  • Not live with a primary caregiver who is legally able to give consent for the youth's participation
  • Be a victim of previously undisclosed abuse requiring investigation or ongoing supervision by the Department of Children and Families.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: GIVE module
The GIVE module consists of one 50-minute treatment session and a second partial session (15-20 minutes) embedded within a larger cognitive behavioral treatment (CBT) protocol for anxiety or depression. The GIVE module uses cognitive behavioral principles to target youth's beliefs that they are a burden or drain on others.
The GIVE Module is a brief cognitive behavioral intervention targeting youths' beliefs that they are a burden or drain on others. It consists of two sessions embedded within a larger CBT protocol for anxiety or depression.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
6-item Youth Perceived Burdensomeness Subscale of the Interpersonal Needs Questionnaire
기간: post-intervention (within one week of completing the GIVE Module)
Youth self-ratings on perceived burdensomeness over the past week. Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 6 and 42. Higher scores indicate higher levels of perceived burdensomeness (worse outcome).
post-intervention (within one week of completing the GIVE Module)

2차 결과 측정

결과 측정
측정값 설명
기간
10-item Youth Rated Warmth Subscale of the Child Report of Parental Behavior Inventory
기간: post-intervention (within one week of completing the GIVE Module)
Youth ratings on parental warmth over the past week. Each of 10 items is scored 1-3 (1 = not like parent; 3 = a lot like parent), yielding a total score of 10 to 30. Higher scores indicate higher levels of parental warmth (better outcome).
post-intervention (within one week of completing the GIVE Module)
10-item Parent Rated Warmth Subscale of the Parent Report of Parental Behavior Inventory
기간: post-intervention (within one week of completing the GIVE Module)
Parent self-ratings on parental warmth over the past week. Each of 10 items is scored 1-3 (1 = not like me; 3 = a lot like me), yielding a total score of 10 to 30. Higher scores indicate higher levels of parental warmth (better outcome).
post-intervention (within one week of completing the GIVE Module)
41-item Youth Rated Screen for Child Anxiety Related Emotional Disorders
기간: post-intervention (within one week of completing the GIVE Module)
Youth self-ratings on anxiety symptom severity. Each item is scored 0-2 (0 = not true; 2 = very true), yielding a total score of 0 to 82. Higher scores indicate higher levels of anxiety (worse outcome).
post-intervention (within one week of completing the GIVE Module)
41-item Parent Rated Screen for Child Anxiety Related Emotional Disorders
기간: post-intervention (within one week of completing the GIVE Module)
Parent ratings on youth anxiety symptom severity. Each item is scored 0-2 (0 = not true; 2 = very true), yielding a total score of 0 to 82. Higher scores indicate higher levels of anxiety (worse outcome).
post-intervention (within one week of completing the GIVE Module)
28-item Youth-rated Children's Depression Inventory - 2
기간: post-intervention (within one week of completing the GIVE Module)
Youth self-ratings on depressive symptom severity. Each item is scored 0-2, yielding total scores of 0 to 56, with higher scores corresponding to more severe symptoms.
post-intervention (within one week of completing the GIVE Module)
17-item Parent Rated Children's Depression Inventory - 2
기간: post-intervention (within one week of completing the GIVE Module)
Parent ratings on youth depressive symptom severity. Each item is scored 0-3, yielding total scores of 0 to 51, with higher scores corresponding to more severe symptoms.
post-intervention (within one week of completing the GIVE Module)
8-item Youth Rated Client Satisfaction Questionnaire
기간: post-intervention (within one week of completing the GIVE Module)
Youth ratings of satisfaction with the GIVE module. Each item is score 1-4 (1 = quite dissatisfied; 4 = very satisfied), yielding total scores of 8-32. Higher scores indicate higher satisfaction (better outcome).
post-intervention (within one week of completing the GIVE Module)
8-item Parent Rated Client Satisfaction Questionnaire
기간: post-intervention (within one week of completing the GIVE Module)
Parent ratings of satisfaction with the GIVE module. Each item is score 1-4 (1 = quite dissatisfied; 4 = very satisfied), yielding total scores of 8-32.
post-intervention (within one week of completing the GIVE Module)

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2019년 3월 20일

기본 완료 (실제)

2020년 12월 30일

연구 완료 (실제)

2020년 12월 30일

연구 등록 날짜

최초 제출

2018년 12월 18일

QC 기준을 충족하는 최초 제출

2018년 12월 18일

처음 게시됨 (실제)

2018년 12월 19일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2021년 6월 8일

QC 기준을 충족하는 마지막 업데이트 제출

2021년 5월 12일

마지막으로 확인됨

2021년 5월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 1F31MH116603 (미국 NIH 보조금/계약)

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다